Trial site
Hospital Universitario De Salamanca
- 275running trials
- 121closed trials
The trials here
What the 402 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma87 trials
- Myelodysplastic syndromes28 trials
- Diffuse large B-cell lymphoma27 trials
- Acute myeloid leukaemia24 trials
- Follicular lymphoma23 trials
- Hodgkin lymphoma23 trials
- Myeloproliferative neoplasms18 trials
- Chronic lymphocytic leukaemia17 trials
- Amyloidosis15 trials
- Mantle cell lymphoma15 trials
- Prostate cancer15 trials
- Childhood cancers14 trials
- and 57 more
- Phase
- Phase 3175 trials
- Phase 2115 trials
- Phase 1/240 trials
- Phase 136 trials
- Phase 2/310 trials
- Phase 410 trials
- Status
- Active, not recruiting137 trials
- Recruiting125 trials
- Completed113 trials
- Not yet recruiting13 trials
- Suspended6 trials
- Terminated6 trials
- Withdrawn2 trials
- Lead sponsor
- Janssen Research & Development, LLC31 trials
- Novartis Pharmaceuticals16 trials
- Celgene10 trials
- Hoffmann-La Roche10 trials
- Regeneron Pharmaceuticals10 trials
- and 193 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Recruiting
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Recruiting
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Recruiting
Recruiting
Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
Not yet recruiting
Recruiting
Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
Recruiting
Recruiting
Recruiting
Showing 50 of 275.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma25 recruiting
- Childhood cancers10 recruiting
- Chronic lymphocytic leukaemia10 recruiting
- Myelodysplastic syndromes10 recruiting
- Diffuse large B-cell lymphoma8 recruiting
- Acute myeloid leukaemia7 recruiting
- Amyloidosis7 recruiting
- Hodgkin lymphoma7 recruiting
- Myeloproliferative neoplasms7 recruiting
- Follicular lymphoma6 recruiting
- Acute lymphoblastic leukaemia5 recruiting
- Heart failure5 recruiting
- Mantle cell lymphoma5 recruiting
- Prostate cancer5 recruiting
- Alzheimer disease4 recruiting
- Colorectal cancer4 recruiting
- Lung cancer4 recruiting
- Asthma3 recruiting
- Chronic myeloid leukaemia3 recruiting
- Head and neck cancer3 recruiting
- High blood pressure3 recruiting
- Pulmonary arterial hypertension3 recruiting
- Bladder cancer2 recruiting
- Chronic kidney disease2 recruiting
- Coronary artery disease2 recruiting
- Cytomegalovirus infection2 recruiting
- HIV2 recruiting
- Hypertrophic cardiomyopathy2 recruiting
- Immune thrombocytopenia (ITP)2 recruiting
- Obesity2 recruiting
- Aortic aneurysm1 recruiting
- Aortic stenosis1 recruiting
- Autism1 recruiting
- Bipolar disorder1 recruiting
- Burkitt lymphoma1 recruiting
- COPD1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Depression1 recruiting
- Dilated cardiomyopathy1 recruiting
- Endometrial cancer1 recruiting
- IgA nephropathy1 recruiting
- Liver cirrhosis1 recruiting
- Lupus (SLE)1 recruiting
- Mesothelioma1 recruiting
- Multiple sclerosis1 recruiting
- Myocarditis1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Psoriasis1 recruiting
- Schizophrenia1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Withdrawn
Recruiting
Recruiting
A Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01]
Completed
GSK4527226 Open-label Extension Study in Patients with Early Alzheimer's Disease.
Completed
A study of AZD2962, an IRAK4 inhibitor, in Participants with Haematologic Neoplasms
Completed
Withdrawn
Active, not recruiting
A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma
Active, not recruiting
Completed
Completed
Active, not recruiting
RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms
Completed
Active, not recruiting
Terminated
Completed
EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE
Completed
Completed
Active, not recruiting
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
Completed
Completed
Completed
BPL-003 Efficacy and Safety in Treatment Resistant Depression
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis
Active, not recruiting
Completed
Completed
A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
Active, not recruiting
Terminated
Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Showing 50 of 121.
Site data: ClinicalTrials.govUpdated 19 Nov 2026